Table 2.
Period | Milestone events, in chronological order | Impact on confirmed rabies | |
---|---|---|---|
|
|||
Cases in dogs | Cases in humans | ||
1888-early 1900’s | Beginning of rabies vaccination in humans with Semple’s type vaccines. | ND | ND |
1960–1979 | Production of suckling-mouse-brain vaccine. | 1960s: ND | 1960s: ND |
Availability of PEP for humans in large cities. | 1979: 23000 | 1979: 310 | |
Vaccination campaigns of owned dogs in large cities. | |||
Dog population management by removal of stray dogs in capital cities. | |||
Introduction of rabies diagnostic units in major cities, based on histopathology (Seller’s staining). | |||
Implementation of direct immunofluorescent antibody test (DFA) in national reference laboratories only. | |||
1980–1990 | Dog rabies is recognized as a public health problem | 1980: 24000 | 1980: 300 |
PAHO/WHO advocates and coordinates rabies control and prevention initiatives throughout | 1990: 8500 | 1990: 270 | |
REDIPRA | |||
Creation of multifunctional anti-rabies centers in major cities. | |||
1991–2015 | Establishment of comprehensive national rabies control and prevention programs for dogs and humans, administered by Ministries of Health with federal budget. | 1991: 16250 | 1991: 240 |
2015: 316 | 2015: 3 | ||
Acquisition of cell culture-derived rabies vaccines for humans and animals | |||
Implementation of a revolving fund administered by PAHO to acquire rabies biologics a cover expenses of cold chain storage | |||
Execution of massive dog vaccination campaigns with intersectoral and community cooperation twice a year. | |||
Establishment of minimum potency policies for human and animal rabies vaccine manufactures to counteract adverse cold chain and field conditions | |||
Implementation of regional financial strategies (PAHO revolving fund) for consolidated acquisition of rabies biologicals for humans and animals at more affordable prices | |||
Creation of decentralized nationwide rabies diagnostic networks, using DFA as gold standard. Improvement of cold chain for human and animal vaccines at Federal, State, Municipal and local levels | |||
Creation of decentralized nation-wide animal control Units | |||
Legislation and enforcement of responsible pet ownership | |||
Embrace policies for elimination and management of stray dog populations in collaboration with NGOs, humane societies and the community. | |||
Communication outreach sponsored by Ministries of Health and the federal government, with intersectoral collaboration. | |||
Technology transfer agreements with WHO collaborating centers on rabies to strengthen laboratory-based rabies surveillance. | |||
Implementation of oral rabies vaccination for free-roaming dogs and wildlife species maintaining dog-specific and dog-related RABV. |
ND: not determined. Source for the numbers of humans and dogs infected with dog-specific RABLV variants: SIRVERA/SIEPI-PANAFTOSA/OPS-OMS (updated to 2015) http://siepi.panaftosa.org.br/. REDIPRA (Reunión de Directores de Programas de Rabia de las Américas), from its acronym in Spanish.